(B) Apparent MWs of the cytosolic ␣S species suggest that they are oligomers. Human wt ␣S-transfected MES neurons were conditioned in the absence of serum and presence of FA-free BSA (to assist delipidation). Samples of high-speed cytosol ‫51ف(‬ g) were incubated at 65ЊC overnight and then Western blotted with LB509. The relative migration of ␣S-specific bands was calculated using a BenchMark prestained protein ladder and AlphaEase (version 5.5) software. 2X through 6X indicate multiples of the monomer (1X). (C) ␣S monomers and higher MW species migrate to the same isoelectric point, supporting the identity of the later as oligomers. High-speed cytosol (10 g) of human wt ␣S transfected MES cells was incubated at 65ЊC overnight and than subjected to isoelectric focusing (IEF) (pH gradient, 3 to 10) followed by SDS-PAGE (8%-16% Tris-Glycine gradient). The 2D gel was blotted with LB509.
protein appeared at the monomer position ‫71ف(‬ kDa) Polyunsaturated Fatty Acids Promote and Saturated Fatty Acids Inhibit the Formation of Soluble ␣S on the gel (Figures 2C and 2E ). However, if these blots were incubated at 65ЊC just before development, the Oligomers in Living Mesencephalic Neurons Both chloroform/methanol and Lipidex extractions re-SEC fractions were shown to contain ␣S dimers ‫53ف(‬ kDa) and some higher oligomers, in addition to the moveal the SDS-stable ␣S oligomers in brain tissue, suggesting the association of the oligomers with lipids. nomers; the detection of the latter was also markedly enhanced ( Figures 2D and 2F ). The S370 fractions from Moreover, we previously identified sequences near the N and C termini of ␣S that are homologous with a conmouse brain tended to have slightly larger ␣S species (range ‫03ف‬ to Ͼ70 kDa) than those of MES cells (range served motif of the fatty acid binding protein (FABP) family (Sharon et al., 2001). These findings led us to ‫.)54-02ف‬ We obtained closely similar results by performing SEC on pure, recombinant human ␣S (data not ask whether the formation and stability of soluble ␣S oligomers are regulated by FAs in intact cells. We supshown). These SEC fractionation and sizing results demonstrate that dimers and higher oligomers of ␣S occur plemented the conditioned medium of MES cells stably expressing wt human ␣S with specific FAs. In these in the high-speed soluble fraction of both ␣S-expressing MES cells and normal mouse brain in the absence of a experiments, BSA was used as a vehicle to introduce the FAs into the cells (at a BSA:FA ratio of 1:5) (Bonen denaturing treatment. Moreover, soluble ␣S oligomers that have been gel-separated and fixed onto memet al., 1999; Schaffer and Lodish, 1994). MES cells grown overnight in serum-free medium supplemented with FAbranes are not detected well unless the membranes are exposed to heat, a treatment that may remove ␣S-free BSA served as the control condition to establish basal levels of ␣S oligomers in the high-speed (S370) associated lipids to expose ␣S epitopes (see Discussion). When we heated the SEC fractions at 65ЊC before cytosol. In parallel, sister cultures were grown overnight in serum-free medium supplemented with BSA plus spegel electrophoresis/Western blotting, the heating again increased the amounts of oligomers as well as monocific FAs. After overnight incubation, the S370 samples were blotted for ␣S oligomer content. Because the total mers detectable on the blots, similar to the result obtained if the unheated fractions were run and then the FA concentration in normal human plasma is about 500 M, we initially used this concentration for either FA blots were heated (data not shown). Thus, the invariant increase, rather than decrease, in monomer levels that mixtures or individual FAs. [20:1]) had no effect on the levels of ␣S oligomers in the excluded material ( Figure 3A ). When carbon chain length was held constant, there was a direct correlation be-S370 cytosol compared to BSA alone, conditioning the cells in saturated FAs (stearic acid [18:0] or arachidic tween the degree of unsaturation (number of double bonds) and the level of ␣S oligomerization; the more acid [20:0]) resulted in a striking and consistent decrease in the levels of ␣S oligomers, without appreciably changunsaturated the FA was, the more effective it was in promoting the appearance of ␣S oligomers ( Figure 3A ). ing monomer levels ( Figure 3A) (Figure 3B) . In each case, the longer chain PUFA enhanced either actively by protein transporters or via flip-flop of the FA through the membrane (Hamilton, 1999). We the levels of soluble dimers and oligomers more potently. The effect of carbon chain length was less protherefore asked how soon after a cell is exposed to extracellular FA can the enhancement of ␣S oligomerizanounced than that of degree of saturation. Nevertheless, densitometric analyses confirmed that the oligomer levtion be observed. We assumed that a rapid response might suggest that ␣S was reacting to the FA itself, els rose about 2-fold within each pair we compared (not shown).
whereas a delayed response might suggest that it was reacting to a FA metabolite or complex lipid molecule. We also conducted in vitro FA incubation studies on pure ␣S that had first been subjected to size exclueffect. ␣S oligomerization was enhanced by DHA in a dose-dependent fashion between 10 and 1000 M (Figsion chromatography. Beginning with the SEC-purified monomer alone, we were able to show unequivocally ures 4A and 4B). Importantly, in the case of purified ␣S, there was no need for heat treatment in order to detect that it oligomerizes in the presence of PUFAs, thereby excluding the remote possibility that the PUFAs were the oligomers by Western blotting. The dimer (35 kDa) of pure ␣S observed by silver staining after incubation disaggregating some hypothetical higher MW ␣S aggregates (data not shown). with DHA at Ͼ10 M migrated at the same position as the presumptive dimers we had identified by Western blotting in intact ␣S-transfected MES cells incubated Soluble ␣S Oligomers Accumulate More Rapidly in Cells Expressing A53T Mutant Human ␣S with PUFA ( Figure 4C ). Incubation of pure ␣S with PUFA not only promoted its oligomerization but was also assoTo explore the relevance of the soluble ␣S oligomers described above to the pathogenesis of ␣-synucleinociated with the detection of increased (rather than decreased) levels of monomeric ␣S by Western blotting pathies like PD, we compared MES neuronal lines stably expressing wt or A53T mutant human ␣S. Five different ( Figure 4A ). In addition, SDS sample preparation and subsequent SDS-PAGE never led to in vitro oligomerizamatched pairs of wt and A53T clones were compared for soluble high MW ␣S immunoreactivity accumulating tion of pure ␣S monomer (e.g., Figures 4A and 4B , extreme right lanes). These findings again support the conwith time in culture; a representative pair of clones is shown in Figure 5 . The clones were matched for closely clusion that the highly soluble ␣S oligomers we detect in the cytosols of MES neurons and brains exist in vivo. similar expression levels of ␣S monomer and were maintained identically under normal serum conditions from We next examined the effects on the oligomer pattern of incubating pure ␣S in DHA for prolonged periods. the time of initial DNA transfection through selection of stable clones and then serial passage in culture. S370 After 48 hr, the overall level of oligomeric species detected by Western blotting was increased (compared to was prepared at increasing time points posttransfection; equal protein aliquots were incubated at 65ЊC, electro-2 hr) in samples containing 100 or 1000 M DHA ( Figure  4A ). In particular, more high MW (Ն35 kDa) oligomers phoresed in parallel, and Western blotted for ␣S monomers and oligomers. Early during clonal lifetime (63 days extending up the running gel were observed, and this change was accompanied by less monomers and diposttransfection), the content of human ␣S oligomers was very low in the wt clones but was already appreciamers than were seen at 2 hr. These Western blot changes were generally reflected by the less sensitive method ble in the matched A53T clones (compare Figures 5A and 5B). Thereafter, both the wt and A53T clones of silver staining, in which the dimer was far less visible at 48 hr than at 2 hr at DHA concentrations of 10, 50, showed first a time-dependent accumulation and then a loss of oligomers. We quantified the ratio of all ␣S-and 100 M (Figure 4B ). At the highest FA concentration (1000 M), the trimer band became visible by silver stainreactive species Ն35 kDa (oligomers) to the 17 kDa species (monomers) ( Figure 5C ). This ratio was far higher wt tg ␣S (LB509) as well as for endogenous mouse ␣S (H3C) (Figure 6 ). We confirmed the specificity of this in the A53T-than wt-expressing clones already at the earliest posttransfection time point we measured (63 high MW ␣S reactivity, by showing the same patterns with the additional antibodies 15G7 (human-specific) days). (Earlier time points could not be taken, because it took ‫06ف‬ days to select stable clones after DNA transand syn-1 (both mouse and human ␣S) (data not shown). We also preabsorbed each antibody with purified, refection.) There was further accumulation of oligomers over time in both the wt and A53T clones, but the maxicombinant ␣S (Figures 6A and 6B ). Both the dimer and the high MW smear at ‫58ف‬ kDa and above was ␣S-mal oligomer:monomer ratio was reached somewhat earlier in the case of the A53T clones. After ‫001ف‬ days specific, whereas a ‫52ف‬ kDa band appearing in the older mice was nonspecific. in culture, we observed a striking decline in total ␣S levels, with the oligomers declining more rapidly than the monomers, resulting in falling ratios. This decline is related to the overall loss of ␣S expression that we we expressed the results as a ratio between the levels of 35 kDa (dimeric) and 17 kDa (monomeric) ␣S meaand compared these to the pattern of endogenous ␣S in the same mice. Equal protein aliquots of S370 supersured in the same sample (i.e., the same gel lane). In the high-speed cytosols, ␣S monomers, dimers, and natants from young and old tg brains were incubated at 65ЊC and then analyzed by Western blotting. To detect some higher MW oligomers were detected after incubation at 65ЊC ( Figure 7A ). We observed a significant ‫-2ف‬ solely the human ␣S protein, we used antibodies LB509 and 15G7, whereas for total ␣S (endogenous mouse fold increase in the 35/17 kDa ␣S ratio in the cytosols of both PD and DLB brains, compared to that in simultaplus transgenic human), we used antibodies H3C and Syn-1. Comparisons with non-tg littermates revealed neously analyzed controls ( Figure 7D ) (p Ͻ 0.005 for PD and p Ͻ 0.01 for DLB). The detection of the higher MW that the level of brain expression of human ␣S was about a half of that of endogenous mouse ␣S (not shown). We oligomers was strongly enhanced by incubating the cytosols with the fatty acid binding resin, Lipidex1000, at found that brain levels of ␣S monomers were similar for young (4 week) and old (18 month) mice. Using H3C 65ЊC and analyzing the material that was bound to the Lipidex, as previously reported ( Figure 7B ; Sharon et antibody, we detected a modest accumulation of the dimer in old compared with young mice (Figure 6A) . The al., 2001). In the case of the lipid-rich, low-speed fraction of brain homogenates that floats above a sucrose cushdimer was not observed with antibody LB509, probably due to its low abundance ( Figure 6B ). However, substanion, we extracted this fraction in chloroform/methanol (2:1) and then Western blotted the residual water-soluble tial differences between young and old mice were detected in the higher MW ␣S species. In the older mice, material. Here, we observed very high MW ␣S-immunoreactive material migrating only in the stacking gel down we observed accumulation of soluble ␣S oligomers, specifically accumulation of a ‫58ف‬ kDa band and a to its interface with the resolving gel, and this was consistently present in the PD and DLB samples but absent higher immunoreactive smear migrating up to the gelexcluded region. This pattern was observed for human in the controls ( Figure 7C ). Here, we define and characterize a normal cellular and do not result from in vitro aggregation of ␣S monomer induced by the 65ЊC treatment and SDS-PAGE that pool of entirely soluble ␣S oligomers whose formation and stability are regulated by saturated and polyunsatuwe use to immunodetect them. Both dimers and higher oligomers were separated by SEC performed in physiorated fatty acids. Importantly, the soluble ␣S oligomers are detectable in the very high-speed cytosols of mesenlogical buffer, and they eluted in fractions clearly corresponding to sizes greater than monomer (Figure 2 ). Furcephalic neuronal cells, mouse brains, and human brains. The detection of these SDS-stable, soluble interthermore, after the SEC fractions were electrophoresed (without any heating) and fixed to PVDF membranes, mediates by Western blotting depends on protocols that include a delipidation step. In this regard, we applied heating these membranes to 65ЊC enhanced the detection of both oligomers and monomers in a step that the chloroform/methanol extraction method (Sharon et al., 2001) to remove lipids from ␣S-oligomers and enable could not allow further aggregation of the monomers. Heat and delipidation (Lipidex; chlorform/methanol) their detection by antibodies. We further show that the soluble ␣S oligomers accumulate with time in the cytotreatments that reveal the soluble oligomers are invariably associated with detection of more, rather than less, plasm of cultured mesencephalic dopaminergic cells and that this accumulation is accelerated by expressing monomers, further obviating the possibility that these treatments are inducing ␣S aggregation in vitro. Morethe PD-causing A53T mutation. In accord, the appearance of soluble ␣S oligomers in mouse brain was found over, SDS solubilization of S370 samples and denaturing gel electrophoresis was never found to induce the oligocluded a pretreatment (Lipidex1000 extraction) aimed at removing lipids, especially FAs, from the purified remerization of either the natural or recombinant ␣S monomers. Rather, SDS-PAGE of fractions eluting from the combinant ␣S protein prior to its incubation with FAs. This may make ␣S more able to bind FAs at lower con-SEC column at Ն35 kDa (dimers and oligomers) appears to induce partial depolymerization of these metastable centrations and at a faster rate. The oligomerization of ␣S has also been observed in cellular experiments oligomers to release monomers (Figure 2) .
In view of the ability of lipid extraction to markedly utilizing chemical crosslinking with the reducible crosslinker DTBP (Cole et al., 2002) . On this basis, Cole and enhance the detection of soluble ␣S oligomers in the cytosol, we asked whether their formation and/or stabilcoworkers suggested that ␣S exists in cells in an equilibrium of monomers and oligomers and that the crosslinkity were regulated by the fatty acid content of a cell. Conditioning intact MES neurons with physiological ing stabilized existing oligomers. These findings are compatible with our own, although we did not require (plasma) levels of different fatty acids revealed that PUFAs promote the appearance of oligomers in the cycrosslinking to detect a population of SDS-metastable oligomers in our cell and brain cytosols. One difference tosol in a time-dependent fashion. Increasing the extent of unsaturation of the FA strikingly enhanced the between the two studies is the cell lines used: we studied MES cells with dopaminergic properties, whereas Cole amounts of soluble ␣S oligomers detected in the treated cells. Conversely, MES cells conditioned with fully satuand coworkers examined HEK293 cells. This difference raises the possibility that certain cell-specific factors in rated FAs consistently showed lower amounts of soluble ␣S dimers and oligomers than those exposed to monodopaminergic neurons might help to promote or stabilize ␣S oligomers. In this regard, recent findings suggest a unsaturated FAs or to the BSA carrier protein alone. We obtained evidence that these regulatory effects reprepositive role for PUFAs in the maintenance of dopamine levels and the amounts of dopamine-containing lipid sent, at least in part, a direct action of the FAs on ␣S by incubating purified human ␣S in vitro with DHA. This vesicles in neurons (Zimmer et al., 1998 (Zimmer et al., , 2000 . Based on our collective findings, we speculate that resulted in the dose-and time-dependent formation of SDS-stable oligomers of the pure protein, similar to ␣S monomers interact in the neuronal cytoplasm with FAs, and that certain FAs, particularly longer and more those observed for native ␣S in the cytosols of the PUFAtreated MES cells, in ␣S transgenic mouse brains, and unsaturated molecules, help mediate the formation of early, soluble oligomers. The oligomers appear to exist in the brains of humans with PD or DLB.
In our in vitro assays, we observed the de novo apnormally in small amounts; however, over time (i.e., during aging) or with prolonged exposure to PUFAs in the pearance of dimers and trimers of pure ␣S within 2 hr of incubation with PUFA (Figure 4) , and in intact dopaneuronal cytoplasm, a portion of them may aggregate into much larger, insoluble assemblies, as we observed minergic mesencephalic cells, the oligomers began accumulating within 1 hr after supplementing the medium in both mesencephalic neurons and transgenic mice. According to this hypothetical model, the ability of ␣S with PUFAs ( Figure 3C ). Further, our results indicate that the transition from soluble to insoluble (gel-excluded) to interact with FAs in the cytoplasm, during which a portion of ␣S is converted into highly soluble, lipid-assooligomers is also FA dependent. At early time points (1-6 hr) of incubation with ALA, there was clear enhanceciated oligomers, may constitute part of the physiological function of the protein. We base the latter assumpment of the soluble oligomers (migrating at 35 to ‫021ف‬ kDa), but after longer incubation times (18 hr), there was tion on the following observations: (1) soluble oligomers of endogenous ␣S appear in normal mouse brain as a major reduction in these oligomers but an increase in ␣S-reactive gel excluded material (Figures 3A-3C ). We early as 3 weeks of age; (2) soluble oligomers respond very rapidly to changes in the lipid environment, being hypothesize that this gradual progression in the size and insolubility of ␣S assemblies represents an analog induced in intact MES neurons after just 1 hr of incubation in physiological extracellular concentrations of of the changes in ␣S solubility and aggregation state reported in PD and other synucleinopathies. In this rePUFAs; and (3) the soluble oligomerization process is reversible, in that there is inhibition and apparent disasgard, we document abnormally elevated amounts of both soluble and gel-excluded forms of lipid-associated sembly of oligomers when ␣S-expressing cells are exposed to physiological levels of saturated FAs. ␣S in PD and DLB brains (Figure 7) .
Of direct relevance to our findings is the recent report It is likely that the accumulation of soluble oligomers beyond a certain level becomes harmful for neurons. In that purified human ␣S oligomerized in the presence of phospholipid vesicles that contained long-chain PUFAs the three systems we examined here, we found support for the hypothesis that the time-dependent accumulaand that this was detected as early as 12 hr after adding the vesicles ( an 11 cm 1D ready-strip (Bio-Rad) with a pH gradient of 3-10. The the initial low-speed (post-170 ϫ g ϫ 15 min) pellet of the homogestrip was overlaid with mineral oil to eliminate drying. Sample was nate was loaded on a 2.15 M sucrose cushion and spun at 60,000 ϫ subjected to the following steps: rehydration for 12 hr, isoelectirc g ϫ 1 hr. The lipid-rich fraction is taken from the top of the cushion.
focusing at 500 V for 30 min followed by 1000 V for another 30 min and 8000 V for 7 hr. As focusing proceeded, the current across the Chloroform/Methanol Extraction of Whole-Mouse Brain strip was dropped to 35 A. The 1D strip was then equilibrated in The procedure was modified from one used to isolate and purify 10 ml equilibration buffer ( 
